Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ATT Injections
- Development stage
- Preclinical
- Lead developer
- Pharmesis International
- Administration
- Injection
01
Overview
ATT Injections is an injectable traditional Chinese medicine (TCM) formulation developed by Pharmesis International for the treatment of liver diseases. It is derived from the herb *Ganhuangcao* (*Penthorum chinense* Pursh), which is traditionally utilized in China for its hepatoprotective, anti-inflammatory, and jaundice-reducing properties. The 'ATT' designation stands for Anti-Tuberculosis Therapy, highlighting the drug's specific utility in mitigating drug-induced liver injury (DILI) associated with tuberculosis treatments. This injectable formulation is a line extension of the company's SFDA-approved Gansu (ATT) capsules and is currently in the preclinical stage of development, with patent applications planned in China.
- Brand names
- Gansu肝苏
- Other names
- Gansu Injections肝苏注射液Ganhuangcao InjectionsAnti-Tuberculosis Therapy Injections
Beyond the preview
Go deeper on ATT Injections.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ATT Injections.